Cellosaurus logo
expasy logo

Cellosaurus Mel Il (CVCL_B6KD)

[Text version]
Cell line name Mel Il
Synonyms mel Il; Mel IL; mel IL
Accession CVCL_B6KD
Resource Identification Initiative To cite this cell line use: Mel Il (RRID:CVCL_B6KD)
Comments Group: Patented cell line.
Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 686D.
Derived from site: Metastatic; Chest, hypodermis; UBERON=UBERON_0001443+UBERON_0002072.
Sequence variations
  • Mutation; HGNC; 1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (CelloPub=CLPUB00680; PubMed=28881731; PubMed=30551515).
Disease Melanoma (NCIt: C3224)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_B6KF (Mel IL/R)CVCL_B6LC (Mel ILG)
Category Cancer cell line
Publications

CLPUB00681
Berezhnoy A.E., Zakeyeva I.R., Kibardin A.V., Chernysheva A.D., Moiseyenko V.M., Danilov A.O., Demidov L.V., Baryshnikov A.Y., Gnuchev N.V., Georgiev G.P., Larin S.S.
Analysis of HLA-E expression in human melanoma cells.
Ross. Bioterap. Zh. 5:66-71(2006)

Patent=RU2287577
Mikhailova I.N., Baryshnikov A.Y., Morozova L.F., Burova O.S., Demidov L.V., Lukashina M.I., Larin S.S., Georgiev G.P., Vorozhtsov G.N., Gnuchev N.V.
Human melanoma cellular line mel IL used in preparing antitumor vaccine.
Patent number RU2287577, 20-Nov-2006

PubMed=18781128; DOI=10.1097/CMR.0b013e32830e391d
Mikhailova I.N., Kovalevsky D.A., Morozova L.F., Golubeva V.A., Cheremushkin E.A., Lukashina M.I., Voronina E.S., Burova O.S., Utyashev I.A., Kiselev S.L., Demidov L.V., Beabealashvilli R.S., Baryshnikov A.Y.
Cancer/testis genes expression in human melanoma cell lines.
Melanoma Res. 18:303-313(2008)

CLPUB00680
Mikhailova I.N., Baryshnikov A.Y., Morozova L.F., Burova O.S., Shubina I.Z., Kovalevsky D.A., Voronina E.S., Treshalina H.M., Lushnikova A.A., Tsyganova I.V., Mazurenko N.N.
Human skin melanoma cell lines collection.
(In) Management of malignant melanoma; pp.1-6; SM Group; Dover (2016)

PubMed=28881731; DOI=10.18632/oncotarget.17014
Emelyanova M., Ghukasyan L., Abramov I., Ryabaya O., Stepanova E.V., Kudryavtseva A., Sadritdinova A., Dzhumakova C., Belysheva T., Surzhikov S., Lyubchenko L., Zasedatelev A., Nasedkina T.
Detection of BRAF, NRAS, KIT, GNAQ, GNA11 and MAP2K1/2 mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis.
Oncotarget 8:52304-52320(2017)

PubMed=30551515; DOI=10.1016/j.biopha.2018.11.109
Ryabaya O., Prokofieva A., Akasov R., Khochenkov D., Emelyanova M., Burov S., Markvicheva E., Inshakov A., Stepanova E.V.
Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells.
Biomed. Pharmacother. 109:2548-2560(2019)

Cross-references
Cell line databases/resources cancercelllines; CVCL_B6KD
Encyclopedic resources Wikidata; Q112129273
Entry history
Entry creation17-Mar-2022
Last entry update05-Oct-2023
Version number5